Brown Brothers Harriman & Co. grew its position in The Allstate Co. (NYSE:ALL – Free Report) by 250.4% during the third quarter, HoldingsChannel reports. The firm owned 4,121 shares of the insurance provider’s stock after buying an additional 2,945 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Allstate were worth $782,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also modified their holdings of the company. Independent Advisor Alliance raised its holdings in Allstate by 227.4% in the 3rd quarter. Independent Advisor Alliance now owns 20,498 shares of the insurance provider’s stock worth $3,888,000 after acquiring an additional 14,237 shares during the period. Harvest Fund Management Co. Ltd increased its stake in shares of Allstate by 66.8% in the third quarter. Harvest Fund Management Co. Ltd now owns 4,572 shares of the insurance provider’s stock worth $867,000 after purchasing an additional 1,831 shares during the period. Daiwa Securities Group Inc. lifted its position in shares of Allstate by 52.1% during the 3rd quarter. Daiwa Securities Group Inc. now owns 55,249 shares of the insurance provider’s stock worth $10,478,000 after purchasing an additional 18,930 shares during the last quarter. Summit Trail Advisors LLC boosted its stake in Allstate by 6.8% during the 3rd quarter. Summit Trail Advisors LLC now owns 19,573 shares of the insurance provider’s stock valued at $3,730,000 after purchasing an additional 1,245 shares during the period. Finally, Crewe Advisors LLC grew its holdings in Allstate by 5.1% in the 3rd quarter. Crewe Advisors LLC now owns 2,282 shares of the insurance provider’s stock valued at $433,000 after buying an additional 110 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Allstate
In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the sale, the insider now owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This represents a 57.06 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.80% of the stock is currently owned by company insiders.
Allstate Trading Up 2.9 %
Allstate (NYSE:ALL – Get Free Report) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.81 earnings per share. Research analysts expect that The Allstate Co. will post 16.07 earnings per share for the current fiscal year.
Allstate Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Stockholders of record on Friday, November 29th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.77%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the company. UBS Group upped their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Keefe, Bruyette & Woods upped their target price on shares of Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a research note on Wednesday, November 6th. Jefferies Financial Group raised their price target on shares of Allstate from $231.00 to $267.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Bank of America upped their price objective on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, The Goldman Sachs Group increased their target price on shares of Allstate from $209.00 to $230.00 and gave the company a “buy” rating in a research note on Friday, November 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $217.19.
View Our Latest Stock Analysis on ALL
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- 3 Small Caps With Big Return Potential
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- How to Find Undervalued Stocks
- Why Amazon Shares May Never Trade Below $200 Again
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.